.25 mg semaglutide weight loss Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Arti Thangudu MD|Endocrinologist (Diabetes/Thyroid/Weight Loss)
Pay in 4 interest-free payments of $7.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7






















![Vorratsdosen-Set [Warschau] material:Alloyed steel](https://cdn.shopify.com/s/files/1/0768/3365/3081/files/02.1.jpg?v=1728673378)


